Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Shortage reports
Actual shortage:
20 (19%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
83 (80%)
104
Discontinuation Reports
To be discontinued:
3 (33%)
Discontinued:
6 (67%)
Reversed:
0 (0%)
9
16 (14%)
17 (74%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Avoided shortage | 2022-10-21 | 2023-06-14 | 172409 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2022-10-06 | 2023-06-02 | 171228 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2019-05-28 | 2021-04-22 | 85112 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2018-07-12 | 2018-09-04 | 55518 |
| ATROPINE INJECTION BP | 0.6MG | SOLUTION | Resolved | 2023-11-17 | 2024-04-17 | 210691 |
| ATROPINE INJECTION BP | 0.4MG | SOLUTION | Resolved | 2023-11-17 | 2024-04-16 | 210686 |
| ATROPINE INJECTION BP | 0.4MG | SOLUTION | Resolved | 2018-08-10 | 2018-09-04 | 57885 |
| BACLOFEN INJECTION | 0.05MG | SOLUTION | Actual shortage | 2023-05-26 | 2023-05-27 | 193244 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-07-06 | 182608 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2019-07-05 | 2021-08-12 | 88566 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-12-18 | 2018-06-05 | 33371 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-09-11 | 2017-11-09 | 21857 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-06-07 | 8815 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2023-02-02 | 2023-05-08 | 183209 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-09-11 | 2017-11-17 | 21860 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2018-01-08 | 2018-08-08 | 35122 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-07-05 | 2019-12-19 | 88563 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2018-09-28 | 2018-10-20 | 62580 |
| CEFUROXIME FOR INJECTION, USP | 1.5G | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-08-13 | 122222 |
| CEFUROXIME FOR INJECTION, USP | 7.5G | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-08-13 | 122225 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-07 | 253339 |
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253342 |
| DORZOLAMIDE AND TIMOLOL EYE DROPS BP | 5MG 20MG | SOLUTION | Discontinued | 2024-11-01 | 2025-10-08 | 241852 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Discontinued | 2024-10-01 | 2024-10-02 | 239073 |
| LATANOPROST OPHTHALMIC SOLUTION | 50MCG | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253336 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 9 of 9